Image 1_Metabolomic changes associated with treatment response of neoadjuvant chemotherapy with TEC regimen in HER2-negative breast cancer.pdf

Image 1_Metabolomic changes associated with treatment response of neoadjuvant chemotherapy with TEC regimen in HER2-negative breast cancer.pdf

Introduction<p>This study aimed to characterize time-dependent metabolic alterations and identify metabolites associated with treatment response in HER2-negative breast cancer patients undergoing neoadjuvant chemotherapy (NAC) with the TEC regimen (docetaxel, epirubicin, and cyclophosphamide)....

Full description

Saved in:
Bibliographic Details
Main Author: Kun Fang (619812) (author)
Other Authors: Cuiping Wang (401082) (author), Zhenfeng Li (5865902) (author), Li Wang (15202) (author), Xintong Wang (336550) (author), Zhenwei Jiang (10661874) (author), Mengyuan Wu (9647167) (author), Shuo Diao (1967698) (author), Mingming Yu (1838983) (author), Hai Yang (1646371) (author), Sherwin K. B. Sy (13987452) (author), Pan Deng (2258611) (author), Qiang Mu (19192159) (author)
Published: 2025
Subjects:
Pharmacology
TEC regimen
breast cancer
biomarker
metabolomics
treatment response
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items